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Glomerular localization of circulating antiglobulin activity in essential
mixed cryoglobulinemia with glomerulonephritis. Kidney biopsy sam-
ples from 27 patients with essential mixed cryoglobulinemia of the IgG-
IgM(k) type and glomerulonephritis were studied to assess whether
glomerular immunodeposits display antiglobulin (AG) activity similar to
that of serum cryo-IgM. A preparation of heat-aggregated human IgG
(FAIgG) was used to search for tissue AG activity, and blocking tests
and reactivity tests were carried out to define the nature of this activity.
Glomerular localization of FAIgG was observed in 17 out of 27 kidney
specimens, the positive findings being always associated with 1gM
deposits. Prior exposure of tissue sections to anti-lgM serum blocked
the FAIgG reaction, but no such effect was produced by the pretreat-
ment with other antisera. The positive FAIgG tissue specimens yielded
a similar fluorescence pattern with aggregated alkylated-reduced IgG,
but did not react at all with the aggregated F(ab')2 or aggregated
albumin. The 1gM recovered in the eluate of a kidney biopsy specimen
displayed AG activity. Patients with AG deposits showed more severe
histologic changes and a greater renal functional impairment than did
those without. The data support the notion that circulating cryo-lgM
anti-IgG participates in the formation of glomerular immunodeposits
and in the genesis of renal damage.
Localisation glomerulaire de l'activité circulante antiglobuline au cours
de Ia cryoglobulinemie mixte essentielle avec glomérulonéphrite. Les
biopsies rénales de 27 malades atteints de cryoglobulinémie mixte
essentielle du type lgG-lgM(k) et de glomerulonéphrite ont été étudiées
estimer si les dépôts glomerulaires immuns ont une activité antiglobu-
line (AG) semblable a celle de Ia cryo-lgM serique. Une preparation
d'IgG humaine agrégée par Ia chaleur (FAIgG) a été utilisée pour
étudier l'activité AG du tissu alors que des tests bloquants et destests de
réactivité ont été réalisés Ia nature de cette activité. Une localisation
glomerulaire de FAIgG a ete observée dans 17 parmi les 27 échantillons
de rein, cette localisation a toujours été associée a des dépôts d'IgM.
L'exposition préalable des coupes a un serum anti-IgM a bloqué Ia
reaction de FAIgG mais cet effet n'a pas été produit par le pre-
traitement au moyen d'un autre antiserum. Les échantillons positifs
pour FAIgG ont donné une image en fluorescence semblable avec de
I'IgG agrégée a activitC réduite mais n'ont pas réagi avec F(ab')2
agregee ou I'albumine agregée. L'lgM obtenue par élution d'un echan-
tillon de biopsie rénale a montre une activité AG. Les malades porteurs
de dépôts d'AG avaient des modifications histologiques plus impor-
tantes et une alteration de Ia fonction rénale plus grande que ceux qui en
étaient dépourvus. Ces observations sont en faveur de La notion selon
laquelle Ia cryo-lgM circulante anti-IgG participe a Ia formation de
dCpôts immuns glomerulaires et a Ia genese de lesions rénales.
globulins themselves are strongly suspected as the offending
immune reactants [1—4].
This work was undertaken to provide further support to the
hypothesis that the circulating cryoglobulins are involved in the
genesis of glomerulonephritis through their deposition in the
glomeruli. We thought that if the serum cryoglobulins partici-
pate in the formation of glomerular immunodeposits, these
latter should contain a moiety displaying antiglobulin (AG)
activity in the same way as one cryoglobulin component,
usually the 1gM, does. Hence, we tried to assess whether (a) the
glomerular immunodeposits show AG activity and, if so, wheth-
er (b) this activity derives from circulating cryo-IgM, and (c)
bears some relationship with the degree of renal damage.
Methods
Patients. The study was carried out on 27 patients with EMC
who had been admitted during the years 1975 through 1980 to
any one of the four renal units participating in this study.
Diagnosis of EMC was established after having excluded lym-
phoproliferative disorders and other primary diseases known to
cause cryoglobulinemia, such as SLE, acute poststreptococcal
glomerulonephritis, and so on. None of them had HBs antigene-
mia. All patients showed kidney involvement manifested by
pathologic urinary findings (proteinuria and/or microhema-
tuna), mild to severe impairment in renal function, and consis-
tent histologic changes on renal biopsy samples. Other system
involvement and the relevant data of these patients are reported
in Table 1.
Cryocrit values of sera collected according to the recommen-
dations of Grey and KOhler [2] ranged between 2% and 20%.
Analysis of the cryoprecipitates, carried out in the Center of
Clinical Physiology (CCP) on sera stored at —20° C, according
to previously reported methods [2], showed that serum cryoglo-
bulins were composed of IgG-IgM(k) in 24, and of IgG-IgM(k)-
Clq in the remaining 3 patients (no. 4, Il, 27). Serum AG
activity, assessed by latex agglutination, ranged in reciprocal
An immune complex mechanism likely sustains the renal
involvement that occurs in 20 to 50% of patients with essential
mixed cryoglobulinemia (EMC). Indeed, the circulating cryo-
387
Received for publication February 25, 1981
and in revised form August 17, 1981
0085-2538/82/0021-0387 $01.60
© 1982 by the International Society of Nephrology
388 Maggiore et al
Table 1. Clinical and laboratory data°
a Abbreviations are defined as follows: Scr, serum creatinine; Uprot,
done; CAH, chronic active hepatitis; HML, hepatic minimal lesions.
b Measured as reciprocal x l0.
titer from 100 to 5000 and was almost entirely (90% or more)
cryoprecipitable. Twenty-five patients had reduced serum lev-
els of one or more of the three complement factors (C3, C4,
Clq) that were routinely assayed by radial immunodiffusion.
Kidney tissue specimens, obtained in each of the 27 patients
by either percutaneous (23 patients) or open biopsy (4 patients),
were processed for light and immunofluorescence microscopy.
Each specimen contained from 5 to more than 60 glomeruli,
with most of them containing 10 to 20 giomeruli.
Immunofluorescence. The fluorescence studies were carried
out by an independent observer (FB) on tissue that had been
stored at —80° C. The frozen kidney slices were tested by the
direct immunofluorescence technique with rabbit monospecific
fluorescein-labeled antisera against human 1gM, IgG, IgA, C3,
C4, Clq, light chain of either kappa and lambda type, fibrino-
gen, and albumin. For the C3 activator (C3A), the indirect
fluorescence technique was used. All these antisera were
purchased from Behringwerke.
The assay for tissue AG activity was carried out on unfixed
sections with a solution of fluoresceinated aggregated human
IgG (FAIgG) prepared from commercial Cohn fraction II ac-
cording to the method of Rossen et al [5]. The specificity
control of the reaction with the FAIgG was assessed by treating
the tissue kidney sections with a solution of unfluoresceinated
AIgG having the same concentration as the labeled preparation
(3 mg/mI). A fluoresceinated preparation of native human IgG
(3.2 mg/mI), obtained from the same batch of commercial Cohn
fraction II, was also used for the immunofluorescence testing;
before use, this preparation was purified through Sepharose 6B
chromatography to remove the aggregated molecules.
To identify the nature of the tissue deposits endowed with
AG activity, we carried out blocking experiments as outlined by
Rossen et al [6]: the unfixed frozen sections were treated with
unconjugated antihuman IgG, IgA, 1gM, and Clq sera, washed
with 0.01 M phosphate buffer saline (pH, 7.2) (PBS), and then
exposed to the FAIgG reagent.
Further studies included the use of fluoresceinated solutions
of aggregated alkylated and reduced IgG (AIR FAIgG) (3
mg/mi), and of aggregated F(ab')2 (3.5 mg/mI), both obtained
from human Cohn fraction 11, and aggregated human albumin
(3.5 mg/mI). These reagents were prepared according to the
methods outlined by Dikler 117], stored at —80° C, and used
within 1 month of their preparation.
In an attempt to reveal blocked AG activity on cryostat
sections, we used partial elution techniques as described by
Koffler, Schur, and Kunkel [8]. Before direct immunofluores-
cence testing for IgG, 1gM, and AG activity was performed,
selected cryostat sections were treated with 0.02 M citrate
buffer (pH, 3.2) for periods of 30 mm to 12 hours; I M or 2 M
sodium chloride for periods of 30 to 120 mm; 1 M or 2 M KI for
periods of 30 to 120 mm. All treatments were carried out at
room temperature. As control, tissue sections were exposed to
PBS for comparable periods of time.
Elution studies. A surgical specimen of kidney cortex weigh-
ing 0.70 g was minced finely, suspended in 15 ml of PBS, and
homogenized in a chilled Waring Blendor for 2 mm. The
Patient
no.
Age!
sex
MAP
mm Hg
Sr
mg/dl
Uprot
g/24 hr
Cryocrit
%
C3 C4
mg/dl
Clq
%
Serum AG
titerh Other findings
I 48/M 126 1.4 3.0 14 35 2 34 2.0 CAH, paresthesias, leg ulcers
2 57/F 123 2.0 2.0 8 35 § 78 1.6 HML, paresthesias, leg ulcers
3 54/F 120 1.5 2.0 7 65 4 45 0.3 Hepatosplenomegaly
4 531M 103 1.1 0.5 2 80 6 ND 0.2 CAH
5 50/M 133 2.0 8.5 4 30 15 72 0.8 Hepatosplenomegaly6 50/M 106 1.3 1.5 5 17 9 20 1.4 CAH
7 68/M 123 1.9 0.7 3 25 § 8 0.2 —
8 60/M 121 3.0 1.0 II 15 § § 0.3 Hepatotnegaly
9 451M 123 2.2 5.2 3 63 § § 0.3 Hepatosplenomegaly
10 641M 126 2.3 1.5 16 42 4 13 0.2 Paresthesias, leg ulcers
11 51/F 126 1.5 2.9 9 60 30 ND 0.2 Hepatomegaly
12 53/F 113 0.7 2.0 17 72 4 ND 0.1 Hepatomegaly
13 65/M 106 1.7 2.6 16 50 ND ND 0.3 Hepatomegaly, Raynaud's phenomenon
l4 54/F 116 3.0 2.5 16 45 10 50 0.6 Hepatosplenomegaly, leg ulcers
15 52/M 103 0.8 0.4 5 54 5 ND 0.3 Hepatomegaly
16 43/M 126 2.0 15.0 20 31 5 ND 1.3 Hepatomegaly
17 52/M 133 1.8 3.0 17 55 40 40 0.6 Hepatomegaly
18 46/M 96 1.0 0.4 6 45 56 60 4.0 Hepatomegaly
19 56/F 150 1.8 0.7 18 36 12 100 5.0 Hepatomegaly, paresthesias, Raynaud's phenomenon
20 48/M 133 1.5 0.0 5 69 7 82 0.6 Hepatomegaly
21 44/M 110 0.8 7.0 4 61 3 76 0.3 —
22 46/F 133 1.8 9.0 2 55 21 77 0.2 Hepatomegaly
23 36/F 123 1.6 5.0 8 95 50 70 0.3 Hepatomegaly
24 64/F 123 1.1 0.1 3 70 36 ND 0.6 —
25 51/F 96 0.6 2.0 15 90 4 ND 0.6 Hepatomegaly
26 55/F 103 0.7 0.6 7 55 4 ND 4.0 Leg ulcers, Raynaud's phenomenon
27 53/M 106 1.6 0.1 2 80 15 78 1.6 CAH
urinary proteins; MAP, mean arterial pressure; §, undetectable; ND, not
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homogenate was washed repeatedly with 30-mi aliquots of PBS
by cold centrifugation at x 15000g for 20 mm. After 20 wash-
ings, the supernatant, which had been concentrated 30-fold in a
cellophane bag against PEG 6000. contained no protein detect-
able at 280-nm spectrophotometric analysis. The pellet was
suspended in 14 ml of 0.2 M glycine buffer (pH. 2.4) and stirred
for 4 hours at room temperature, then incubated overnight at
4° C. After centrifugation, the eluate was dialyzed against 0.1 M
acetate buffer (pH, 4.0), concentrated to the final volume of 2
ml, and then fractionated on Sephadex G-200 chromatography
at 4° C in 0.1 M acetate buffer (pH, 4.0). Two-milliliter fractions
were collected, and their optical density was determined on a
Perkin-Elmer Coleman III spectrophotometer at 280 nm. The
protein fractions obtained were dialyzed against PBS, concen-
trated, and tested for serum proteins by double immunodiffu-
sion on agar plates with rabbit antisera (Behringwerke) to
human serum, Clq, IgG, IgA, 1gM, L chains type kappa and
lambda, and albumin. Antisera were put in the peripheral wells
(4 mm in diameter) and allowed to diffuse for 24 hours before
twice filling the central well (8 mm in diameter) with the sample
to be tested. The IgG and 1gM were quantified by a Behring
laser nephelometer.
Light microscopy. The sections stained with hematoxylin-
eosin, periodic acid-Shiff reagent, Masson's thrichrome, and
silver methenamine were examined by an observer (GBB) to
whom the results of the immunofluorescence examination were
not known. He graded the histologic activity and the severity of
the lesions semiquantitatively from 0 to 3+, taking into account
the following features: endocapillary hypercellularity (endothe-
hal and mesangial), number of polymorphonuclear leucocytes,
epithelial crescents, intraluminal "thrombi," and interstitial
cellular infiltration. The finding of vasculitis was scored 3+.
Overall renal histologic activity was evaluated on the basis of
the severity scores of all these changes.
Statistical analysis. The data were analyzed with the x2test
with Yates' correction and the two-tailed Wilcoxon rank sum
test. The 0.05 level of significance was used to determine
statistically significant results.
Results
Tissue AG activity. The immunofluorescence findings in the
patients with EMC are shown in Table 2. Of the 27 kidney
biopsy samples examined, 26 had glomerular deposits of 1gM,
24 oflgG, 17 ofC3, and 12 of other complement factors of either
the classical or the alternative pathway. The appearance of the
fluorescent staining was similar to that previously reported by
others l—4, 9—13].
Seventeen biopsy specimens stained with the FAIgG (Fig.
IA) in a specific fashion, as documented by the blocking effect
of previous treatment with the unfluoresceinated AIgG. The
tissue staining, which had a granular appearance and sometimes
filled the capillary lumina, was located in every instance at sites
containing 1gM deposits. But several kidney specimens, though
loaded with 1gM deposits, did not react with the FAIgG. In six
instances, positive staining for FAIgG was observed in tissue
specimens not containing deposits of complement factors (Ta-
ble 2).
The treatment with AIR FAIgG yielded results quite similar
to those observed with FAIgG (Table 3 and Fig. 1B) in the 15
patients in whom enough tissue was left to carry out this test.
Moreover, prior incubation of tissue sections with unfluores-
ceinated alkylated and reduced aggregated IgG inhibited the
subsequent staining with the FAIgG, suggesting the same tissue
binding sites were implicated in both reactions. None of the
FAIgG positive specimens stained with the aggregated fluores-
ceinated F(ab')2 (Fig. lC) or the aggregated human albumin
preparations, and only 1 out of 10 bound the native human IgG
(Table 3).
The AG positive tissue specimen with isolated 1gM deposits
(patient 4) stained only for kappa chains when tested with the
specific antisera for both light chains, suggesting that 1gM
deposits were of monoclonal type (Fig. 2, A—D).
In all patients with renal deposits of AG activity, pretreat-
ment of frozen kidney sections with unconjugated anti-IgM
serum blocked the subsequent reaction with the FAIgG (Fig.
ID). By contrast, the pretreatment with unconjugated antisera
against IgG, IgA or Clq had no blocking effect on the FAIgG
staining.
Treatment with salt or acid solutions appeared to affect both
the IgG and the 1gM deposits in much the same way. Of 5
FAIgG-negative specimens examined, none was converted into
positive by the elution procedures, whether by those bringing
about the complete removal of immunoglobulin deposits (0.02 M
citrate buffer pH 3.2 for 2 hours, 2 M sodium chloride for 30
mm, 2 M KI for 2 hours) or by those leaving some amounts of
them in the tissue (1 M sodium chloride for 30 mm; I M KI for 30
mm). The 8 FAIgG-positive specimens lost their FAIgG reac-
tivity after 1gM deposits had been completely or nearly com-
pletely removed by acid or salt solutions. PBS treatment for
comparable periods of time caused only a negligible reduction
in the intensity of the immunofluorescent staining.
Characterization of the kidney eluate. On Sephadex G-200
chromatography, the acid eluate of the open-kidney biopsy
sample obtained from patient 6 yielded one very small protein
peak only, which was eluted with the void volume. When tested
with the panel of antisera, this protein fraction appeared to
contain 1gM solely. Total amount of 1gM recovered was 24 p.g.
All the remaining effluent fractions, after being pooled, dia-
lyzed, and concentrated, reacted only with the anti-IgG serum
in the Ouchterlony plate. Total amount of IgG recovered was 33
g. On further testing, the IgG fraction gave precipitin lines
with both the anti-kappa and anti-lambda sera, whereas the 1gM
fraction reacted with the anti-kappa serum only (Fig. 3). But
because the amount available for testing was at the limit of the
sensitivity of the technique for polyclonal 1gM, we cannot
exclude its presence in the eluate. At the latex test, only the
1gM fraction displayed AG activity, at a titer per unit of weight
similar to that of serum cryo-IgM (Table 4).
Tissue AG activity and renal damage. When grouped accord-
ing to the presence (group 1, 17 patients) or absence (group 2, 10
patients) of AG activity in their biopsy specimens, the patients
did not differ with regard to the prevalence of positive staining
for lgG, 1gM, IgA, and C3. But 9 and 3 patients of group I had
deposits of Clq and C4, respectively, whereas only 1 patient in
group 2 had deposits of Clq (Table 2). The histologic changes
observed at light microscopy in the two groups are compared in
Table 5. Overall histologic activity averaged 8.8 (SD) 2.7 in
group 1 and 4.2 2.9 in group 2, a highly significant difference
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Table 2. Renal histologic pattern and immunofluorescence findingsa
.Patient
no. Histology
. .
Reactivity
with FAIgG
Glomerular deposits
IgG 1gM IgA
—_.
C3 C4 Clq C3A
I MPGN ++T +++ +++T ++ ++ ++ ++ +
2 MPGN + ++ ++ — — — — —
3 MPGN + ++ ++ + + + + +
4 MsPGN ++ — ++ — — — — —
5 MPGN ++ + + — — — — —
6 MPGN +++ +++ +++TA ++ + — + ND
7 MPGN ++T ++ +++T ++ — — — —
8 MPGN ++ +++ +++TA +++ ++ — + —
9 MPGN + ++ +++ — + — — ND
10 MPGN ++ +++ +++ + + — + ND
11 MPGN ++T + +T — — — — —
12 MPGN +++ ++ +++ + + — — ND
13 MPGN + +++ +++ — + + + +
14 MPGN +++ +++ +++TA ++ + — + +
15 MsPGN ++ ++ + — — — — —
16 MPGN ++ ++ ++ — — — + +
17 MPGN + +++ ++ + + — +A —
Total 17 16 17 9 10 3 9 5
18 MPGN — + ++A — — — + —
19 MPGN — +++ +++ — —A — — —
20 MsPGN — + ++ + ++ — — —
21 MPGN — + + — + — — —
22 MPGN — + ++ + + — — —
23 MPGN — + ++T — +++ — — +
24 Vasculitis — -A -A —A -A - -A ND
25 MPGN — ++ ++ + — — —
26 FPGN — + + — ++ — — +
27 MsPGN — — + — + — — —
Total 0 8 9 2 7 0 1 2
a Abbreviations are defined as follows: MPGN, membranoproliferative glomerulonephritis; MsPGN, mesangioproliferative glomerulonephritis;
FPGN, focal proliferative glomerulonephritis; T and A, concomitant tubular and arterial deposits, respectively.
(P < 0.002) due to the higher scores of endocapillary hypercell-
ularity, granulocyte infiltration, intraluminal "thrombi," and
vasculitis in group 1. Compared with controls, both groups had
abnormally low serum levels of C3, C4, and CIq (P <0.01 for
all three variables), but in group I serum levels of C3 and Clq
were significantly lower, and creatinine serum level significant-
ly higher than they were in group 2 (Table 6). The two groups
did not differ significantly as to age, degree of proteinuria, blood
pressure, cryocrit, and serum AG activity titer.
Discussion
So far, the evidence supporting the view that serum cryoglo-
bulins participate in the formation of glomerular immunodepos-
its in EMC glomerulonephritis is indirect, it being based on the
following observations: (1) The mixed cryoglobulins are similar
to immune complexes because they are usually made of a
monoclonal 1gM anti-lgG and a polyclonal IgG that react with
each other by precipitating at cold temperature [1—31. (2) The
immunoglobulin classes of the cryoprecipitates are nearly al-
ways represented within the renal immmunodeposits [1—4. 9—
13]. (3) At electron microscopy examination, the cryoprecipi-
tates show a fibrillar appearance closely resembling that of the
subendothelial deposits of the glomeruli [10. 14].
Extending our previous observations [IS, 16], this study
shows that kidney tissue from the majority (17 out of 27) of
patients with EMC glomerulonephritis contains, like their se-
rum cryoprecipitates, some factor(s) that specifically bind(s) in
vitro the aggregated IgG. Such a prevalance of positive stain-
ings for the FAIgG is restricted to EMC glomerulonephritis and
a few other forms of glomerulonephritis. In fact, in this labora-
tory (CCP), where, since 1978, all kidney biopsy samples are
routinely tested for AG activity, we have so far detected the AG
deposits in only 11 out of the 98 biopsy examinations performed
on patients with a wide variety of glomerulonephritis other than
that associated to EMC. In line with other reports [5, 6, 17, 181,
the positive findings were limited to 3 of 14 patients with SLE
nephritis, 6 of 14 with acute poststreptococcal glomerulonephri-
tis, and 2 of 3 with proliferative extracapillary glomerulonephri-
tis.
We collected several bits of evidence pointing out that tissue
AG activity derives from the circulating cryo-IgM:
(1) In all EMC patients, the serum cryoglobulin component
having AG activity was an IgM(k), and the 1gM was the only
moiety that we consistently detected in association with the AG
activity within the glomeruli.
(2) The tissue specimens with positive FAIgG reaction react-
ed also with the AIR FAIgG, but failed to bind the fluoresceinat-
ed aggregated F(ab')2 and the aggregated albumin reagents.
Such a reactivity profile pertains also to the circulating cryo-
1gM anti-IgG [191. In keeping with 1gM anti-IgG's affinity of 100
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Fig. 1. Serial cryosta sections of a glomerulus incubated with Afluoresceinated aggregated human IgG (FAIgG), B alkylated and reduced FAIgG,
C fluoresceinated F(ab')2, D unfluoresceinated anti-IgM serum followed by FAIgG. Scattered tissue staining outside the glomerulus is due to
autofluorescence or serum precipitates (x245).
Table 3. Association of FAIgG binding with immunofluorescence reactions with AIR FAIgG, aggregated F(ab')2, aggregated albumin, and
native IgG
Reactivity No. of A/R FAIgG Aggr. F(ab')2
with FAIgG patients no. positive no. positive
Positive 10 10 0 0 1
Negative 5 0 0 0 —
AIR FAIgG is alkylated and reduced fiuoresceinated aggregated IgG.
times greater for the aggregated IgG than for the monomeric
IgG [20], in 9 over 10 patients the AG deposits did not react with
the monomeric native human IgG,
(3) The pretreatment of tissue sections with the anti-IgM
unfluoresceinated serum blocked the reaction with the FAIgG,
whereas the pretreatment with the unfluorescejnated anti-IgG,
anti-IgA, or anti-Clq sera had no such effect. A reactivity
pattern like this strongly suggests that the 1gM deposits sustain
tissue AG activity [6]. The alternative explanation that the
FAIgG tissue staining could be sustained by either the Fc
receptors of tissue and/or inflammatory cells (macrophagi and
other) or Clq deposits appears untenable. In fact, as against the
rheumatoid factor, neither Fc receptors nor Clq bind the
alkylated and reduced aggregated IgG [7, 21, 221.
(4) The observation that on specific testing the isolated 1gM
glomerular deposits1 in one patient appeared of monoclonal
kappa type like his circulating cryo-IgM also supports the
notion that this serum cryoglobulin component was the source
of the tissue AG activity.
(5) After purification in acid medium so as to prevent its
reaggregation with IgG, the 1gM present in the eluate of a
kidney biopsy, on which imniunofluorescence studies had dem-
onstrated deposits of 1gM and AG activity within the glomeruli,
displayed antiglobulin activity with nearly the same titer as did
the autologous serum cryo-IgM(k).
I The occurrence of isolated 1gM deposits has been reported by
others [10] in patients with EMC and glomerulonephritis.
Aggr. albumin
no. positive
Native lgG
no. positive
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Fig. 2. Serial cryostat sections of a glomerulus (patient 4) incubated with A fluoresceinated anti-IgM, B fluoresceinated anti-kappa chain, C
fluoresceinated anti-lambda chain, D FAIgG. Scattered tissue staining outside the glomerulus is due to autofluorescence or serum precipitates(x245).
Table 4. Characterization of kidney biopsy eluate in patient 6
Serum Serum Kidney
supernatant cryoglobulins eluate
IgG, mgI dl 350.0
1gM, mgldl 155.0 120
3.3
Ag activity, titer reciprocal 40.0 1400
2.4
AGactivity:IgM 0.2 11
24.0
10.0
Taken together, the above observations provide compelling
evidence that in patients with EMC glomerulonephritis renal
AG activity derives from circulating cryo-IgM anti-lgG. Previ-
ously, Agnello, Koffler, and Kunkel [17] had provided direct
evidence for glomerular localization of circulating 1gM anti-lgG
in SLE nephritis using fluoresceinated idiotypic antiserum.
In a substantial proportion of patients, 10 over 27, the
glomerular 1gM deposits did not display any AG activity. These
negative findings, however, might have been due to the satura-
tion of binding sites preventing their reaction with the aggregat-
ed IgG. Attempts at unmasking blocked AG activity by proce-
Fig. 3. Double dff'usion plate. The 1gM fraction of the kidney eluate dures of partial elution were inconclusive because, as it occurs
(central well) reacts with both anti-lgM serum (well 2) and anti-kappa with other immune complex systems [23], each eluting agent
serum (well 3). No reaction occurred with anti-lambda serum (well I). removed in parallel both IgG and 1gM deposits from the
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Table 5. Kidney histopathology in patients with and without tissue antiglobulin activity
Elementary lesions
Reactivity with FAIgG
X P
Positive
(N = 17)
Negative(N = 10)
Endocapillary hypercellularity 2+
Polymorphonuclear leucocytes infiltration
Epithelial crescents
Intraluminal thrombi
Interstitial infiltration 2+
Vasculitis
13
12
8
12
10
12
3
2
2
2
3
2
3.87
4.58
0.98
4.58
1.09
4.58
<0.05
<0.05
NS
<0.05
NS
<0.05
Table 6. Comparison of patients with and without tissue antiglobulin
activity
Data
Reactivity with FAIgGa
Positive
(N = 17)
Negative
(N 10)
Age, yr
MAP, mm Hg
Serum creatinine, mg/dl
Urine proteins, g/24 hr
Cryocrit, %
Serum AG, titer reciprocal x io
Serum C3c, mg/dl
Serum C4, mg/dl
Serum Clqc, % normal values
54.0 7.0
119.0 10.0
1.8 0.6
3.2 3.6
10.0 6.0
0.6 0.5
45.0 19.0
8.0 11.0
32.7 27.7
50.0 8.0
117.0 18.0
1.2 0.4
2.5 3.3
7.0 5.0
1.7 1.8
65.0 19.0
21.0 20.0
77.5 12.1
NS
NS
<0.04
NS
NS
NS
<0.02
NS
<0.003
a Values are the means SD (N = 50).b By Wilcoxon rank sum test.
Normal values (mean SD): C3, 90.7 21.0; C4, 35.0 7.4; Clq,
98.2 16.6.
cryostat sections. Moreover, it is possible that AG activity was
present at such low levels as to escape the detection system we
used. Studies on kidney specimens large enough to allow
elution and characterization of their 1gM deposits would proba-
bly solve these uncertainties.
We observed that patients with demonstrable glomerular
deposits of AG activity had evidence of more severe histologic
renal lesions, lower serum levels of C3 and Clq, and greater
impairment in renal function than did those without. These
observations, however, although in keeping with previous
reports on other forms of glomerulonephritis [5, 6], do not
provide an answer as to whether the glomerular-entrapped AG
activity plays a pathogenic role or is merely a consequence of
the glomerular damage. We favor the former hypothesis be-
cause the marked reduction or the disappearance of the circu-
lating cryo-IgM anti-IgG, induced by treatment [24—26], results
in the marked improvement of glomerulonephritis.
Why and how circulating AG gets lodged in the glomeruli in
only a proportion of the patients with EMC also remain to be
elucidated. Whatever the mechanism might be, our in vitro
studies showed that the deposits of AG were undersaturated in
their binding capacity of the aggregated IgG. Thus, the glomeru-
ii of these patients contained a moiety which, at least in vitro, is
known to act as an immune reactant capable of binding the
aggregated IgG, monomeric IgG, and immune complexes of
widely varying size t20]. It is tempting to speculate that such
deposits act even in vivo as an amplifying mechanism of the
glomerular localization of the circulating immune complexes
and/or of other immune reactants. This hypothesis would
account for the plentifulness of glomerular immunodeposits so
often observed in EMC glomerulonephritis. Because AG activi-
ty has been detected in the kidney of patients with other forms
of immunologically mediated renal disease {5, 6, 17, 18], this
mechanism might be of much greater importance than previous-
ly thought.
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